The estimated Net Worth of Thomas Girschweiler is at least $37.2 Milhão dollars as of 24 November 2020. Mr. Girschweiler owns over 1,600,000 units of Biolife Solutions Inc stock worth over $1,107,879 and over the last 21 years he sold BLFS stock worth over $36,000,000. In addition, he makes $50,000 as Director at Biolife Solutions Inc.
Thomas has made over 3 trades of the Biolife Solutions Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he sold 1,600,000 units of BLFS stock worth $36,000,000 on 24 November 2020.
The largest trade he's ever made was buying 2,241,826 units of Biolife Solutions Inc stock on 31 December 2005 worth over $246,601. On average, Thomas trades about 272,788 units every 363 days since 2004. As of 24 November 2020 he still owns at least 47,774 units of Biolife Solutions Inc stock.
You can see the complete history of Mr. Girschweiler stock trades at the bottom of the page.
Thomas Girschweiler is the Director of the Company. Thomas Girschweiler was a member of our Board from 2003 to March 2014 and joined the Board again in May 2015. Mr. Girschweiler has been engaged in corporate financing activities on his own behalf since 1996. From 1981 to 1996, he was an investment banker with Union Bank of Switzerland. Mr. Girschweiler is a graduate of the Swiss Banking School. The Board has determined that Mr. Girschweiler is qualified to serve as a director because of his experience in corporate financing activities and his status as a significant stockholder.
As the Director of Biolife Solutions Inc, the total compensation of Thomas Girschweiler at Biolife Solutions Inc is $50,000. There are 12 executives at Biolife Solutions Inc getting paid more, with Michael Rice having the highest compensation of $2,241,770.
Thomas Girschweiler is 61, he's been the Director of Biolife Solutions Inc since 2017. There are no older and 14 younger executives at Biolife Solutions Inc.
Thomas's mailing address filed with the SEC is C/O BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL, WA, 98021.
Over the last 21 years, insiders at Biolife Solutions Inc have traded over $156,215,880 worth of Biolife Solutions Inc stock and bought 12,236,637 units worth $91,960,074 . The most active insiders traders include Partners Master Fund, L.P.C..., Thomas Girschweiler, eWalter Villiger. On average, Biolife Solutions Inc executives and independent directors trade stock every 13 days with the average trade being worth of $1,018,157. The most recent stock trade was executed by Sarah Aebersold on 1 July 2024, trading 3,000 units of BLFS stock currently worth $63,090.
bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
Biolife Solutions Inc executives and other stock owners filed with the SEC include: